These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 25609440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
    Stolina M, Dwyer D, Niu QT, Villasenor KS, Kurimoto P, Grisanti M, Han CY, Liu M, Li X, Ominsky MS, Ke HZ, Kostenuik PJ.
    Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of sclerostin antibody plus parathyroid hormone (1-34) on bone formation in ovariectomized rats.
    Wu J, Cai XH, Qin XX, Liu YX.
    Z Gerontol Geriatr; 2018 Jul; 51(5):550-556. PubMed ID: 28364259
    [Abstract] [Full Text] [Related]

  • 6. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
    Li X, Ominsky MS, Warmington KS, Niu QT, Asuncion FJ, Barrero M, Dwyer D, Grisanti M, Stolina M, Kostenuik PJ, Simonet WS, Paszty C, Ke HZ.
    Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
    [Abstract] [Full Text] [Related]

  • 7. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.
    Tian X, Jee WS, Li X, Paszty C, Ke HZ.
    Bone; 2011 Feb; 48(2):197-201. PubMed ID: 20850580
    [Abstract] [Full Text] [Related]

  • 8. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
    Li X, Niu QT, Warmington KS, Asuncion FJ, Dwyer D, Grisanti M, Han CY, Stolina M, Eschenberg MJ, Kostenuik PJ, Simonet WS, Ominsky MS, Ke HZ.
    Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
    [Abstract] [Full Text] [Related]

  • 9. Effect of lycopene on titanium implant osseointegration in ovariectomized rats.
    Li X, Xue W, Cao Y, Long Y, Xie M.
    J Orthop Surg Res; 2018 Sep 17; 13(1):237. PubMed ID: 30223885
    [Abstract] [Full Text] [Related]

  • 10. Sclerostin antibody prevents particle-induced implant loosening by stimulating bone formation and inhibiting bone resorption in a rat model.
    Liu S, Virdi AS, Sena K, Sumner DR.
    Arthritis Rheum; 2012 Dec 17; 64(12):4012-20. PubMed ID: 23192793
    [Abstract] [Full Text] [Related]

  • 11. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats.
    Liu Y, Rui Y, Cheng TY, Huang S, Xu L, Meng F, Lee WY, Zhang T, Li N, Li C, Ke H, Li G.
    Calcif Tissue Int; 2016 Mar 17; 98(3):263-74. PubMed ID: 26603303
    [Abstract] [Full Text] [Related]

  • 12. Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.
    Virdi AS, Liu M, Sena K, Maletich J, McNulty M, Ke HZ, Sumner DR.
    J Bone Joint Surg Am; 2012 Sep 19; 94(18):1670-80. PubMed ID: 22992878
    [Abstract] [Full Text] [Related]

  • 13. Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody.
    Ominsky MS, Niu QT, Li C, Li X, Ke HZ.
    J Bone Miner Res; 2014 Jun 19; 29(6):1424-30. PubMed ID: 24967455
    [Abstract] [Full Text] [Related]

  • 14. Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
    Chen H, Xu X, Liu M, Zhang W, Ke HZ, Qin A, Tang T, Lu E.
    Bone; 2015 Jul 19; 76():141-8. PubMed ID: 25868799
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sclerostin-Neutralizing Antibody Enhances Bone Regeneration Around Oral Implants.
    Yu SH, Hao J, Fretwurst T, Liu M, Kostenuik P, Giannobile WV, Jin Q.
    Tissue Eng Part A; 2018 Nov 19; 24(21-22):1672-1679. PubMed ID: 29921173
    [Abstract] [Full Text] [Related]

  • 18. Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats.
    Suen PK, Zhu TY, Chow DH, Huang L, Zheng LZ, Qin L.
    Sci Rep; 2015 Oct 23; 5():15632. PubMed ID: 26494536
    [Abstract] [Full Text] [Related]

  • 19. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats.
    Feng G, Chang-Qing Z, Yi-Min C, Xiao-Lin L.
    Int Immunopharmacol; 2015 Jan 23; 24(1):7-13. PubMed ID: 25479724
    [Abstract] [Full Text] [Related]

  • 20. Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model.
    Virk MS, Alaee F, Tang H, Ominsky MS, Ke HZ, Lieberman JR.
    J Bone Joint Surg Am; 2013 Apr 17; 95(8):694-701. PubMed ID: 23595067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.